Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio:: Which variable determines survival of cervical cancer patients?

被引:189
作者
Jordanova, Ekaterina S. [1 ]
Gorter, Arko [1 ]
Ayachi, Ouissarn [1 ]
Prins, Frans [1 ]
Durrant, Lindy G. [4 ]
Kenter, Gerrima G. [2 ]
van der Burg, Sjoerd H. [3 ]
Fleuren, Gert Jan [1 ]
机构
[1] Leiden Univ, Dept Pathol, Med Ctr, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ, Dept Gynecol, Med Ctr, NL-2333 ZA Leiden, Netherlands
[3] Leiden Univ, Dept Clin Oncol, Med Ctr, NL-2333 ZA Leiden, Netherlands
[4] Univ Nottingham, Acad Dept Clin Oncol, Inst Infect Immun & Inflammat, City Hosp, Nottingham NG7 2RD, England
关键词
D O I
10.1158/1078-0432.CCR-07-4554
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the effect of intraepithelial tumor-infiltrating lymphocytes (ieTIL) and their ligands expressed by cervical tumor cells on the outcome of cervical cancer patients. Experimental Design: The prognostic value of ieTILs was investigated in 115 cases of cervical cancer. T-cell subsets, CD57(+) cells, and regulatory T cells (Treg) were enumerated. The associations of these different ieTIL subtypes with human leukocyte antigen (HLA) class I and MHC class I chain-related molecule A (MICA) expression were determined in relation to clinical variables and patient survival. Results: Survival analysis showed that a high number of intraepithelial Treg (FoxP3(+)), a low CD8(+)/regulatory T-cell ratio, and a weak HLA-A expression were all associated with worse survival (P = 0.034, 0.025, and 0.033, respectively, log-rank test). Further stratification of patient groups based on HLA-A-MICA expression and HLA-A-MICA-CD8(+)/Treg ratio revealed an even poorer survival (P = 0.005). In a multivariate Cox analysis, low CD8(+)/Treg ratio (P = 0.047), weak HLA-A-MICA expression (P = 0.003), and weak HLA-A-MICA expression combined with low CD8(+)/Treg ratio (P = 0.002) were all found to be independent unfavorable prognostic predictors in cervical carcinoma (hazard ratios, 2.7, 4.0, and 4.9, respectively). Conclusion: Weak HLA-A-MICA expression combined with low CD8(+)/Treg ratio reveals a patient group with the poorest survival in cervical cancer. As a single variable, low CD8+/Treg ratio was a significant independent unfavorable prognostic factor.
引用
收藏
页码:2028 / 2035
页数:8
相关论文
共 43 条
  • [1] [Anonymous], HIGH ABILITY STUDIES, DOI DOI 10.1080/1359813990100102
  • [2] MHC class I antigens and immune surveillance in transformed cells
    Aptsiauri, Natalia
    Cabrera, Teresa
    Garcia-Lora, Angel
    Angel Lopez-Nevot, Miguel
    Ruiz-Cabello, Francisco
    Garrido, Federico
    [J]. INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 256, 2007, 256 : 139 - +
  • [3] Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: A prognostic study
    Bethwaite, PB
    Holloway, LJ
    Thornton, A
    Delahunt, B
    [J]. PATHOLOGY, 1996, 28 (04) : 321 - 327
  • [4] The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
    Bingle, L
    Brown, NJ
    Lewis, CE
    [J]. JOURNAL OF PATHOLOGY, 2002, 196 (03) : 254 - 265
  • [5] Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions
    Bontkes, HJ
    deGruijl, TD
    Walboomers, JMM
    vandenMuysenberg, AJC
    Gunther, AW
    Scheper, RJ
    Meijer, CJLM
    Kummer, JA
    [J]. BRITISH JOURNAL OF CANCER, 1997, 76 (10) : 1353 - 1360
  • [6] Risk association between human leukocyte antigen - A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women
    Chan, DPC
    Cheung, TH
    Tam, AOY
    Cheung, JLK
    Yim, SF
    Lo, KWK
    Siu, NSS
    Zhou, DX
    Chan, PKS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (10) : 1749 - 1756
  • [7] Chao HT, 1999, EUR J GYNAECOL ONCOL, V20, P136
  • [8] Characiejus D, 2002, ANTICANCER RES, V22, P3679
  • [9] Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    Curiel, TJ
    Coukos, G
    Zou, LH
    Alvarez, X
    Cheng, P
    Mottram, P
    Evdemon-Hogan, M
    Conejo-Garcia, JR
    Zhang, L
    Burow, M
    Zhu, Y
    Wei, S
    Kryczek, I
    Daniel, B
    Gordon, A
    Myers, L
    Lackner, A
    Disis, ML
    Knutson, KL
    Chen, LP
    Zou, WP
    [J]. NATURE MEDICINE, 2004, 10 (09) : 942 - 949
  • [10] Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
    Dave, SS
    Wright, G
    Tan, B
    Rosenwald, A
    Gascoyne, RD
    Chan, WC
    Fisher, RI
    Braziel, RM
    Rimsza, LM
    Grogan, TM
    Miller, TP
    LeBlanc, M
    Greiner, TC
    Weisenburger, DD
    Lynch, JC
    Vose, J
    Armitage, JO
    Smeland, EB
    Kvaloy, S
    Holte, H
    Delabie, J
    Connors, JM
    Lansdorp, PM
    Ouyang, Q
    Lister, TA
    Davies, AJ
    Norton, AJ
    Muller-Hermelink, HK
    Ott, G
    Campo, E
    Montserrat, E
    Wilson, WH
    Jaffe, ES
    Simon, R
    Yang, LM
    Powell, J
    Zhao, H
    Goldschmidt, N
    Chiorazzi, M
    Staudt, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) : 2159 - 2169